Cite
HARVARD Citation
Capone, M. et al. (2018). Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab. Journal for immunotherapy of cancer. 6 (1), p. . [Online].